Drawing for ENDOCYTE EC

USPTO serial 85308111

ENDOCYTE EC

Reviewed by CopyMark Law Group

Reg. 4412917Status 710
Filing date
Status date
Registration date
Oct 8, 2013
Examiner
BHANOT, KAPIL KUMAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ENDOCYTE EC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Frances M. Jagla

Frances M. Jagla Lane Powell PC601 SW Second AvenueSuite 2100Portland, OR 97204

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical preparations for the diagnosis and treatment of diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsSECTION 8 - CANCELLEDJul 6, 2000
042scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trialsSECTION 8 - CANCELLEDJul 6, 2000

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2020C8..CANCELLED SEC. 8 (6-YR)—
Oct 8, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 12, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 8, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 4, 2013TMBNTTAB RELEASE CASE TO TRADEMARKS—
Sep 4, 2013OP.TOPPOSITION TERMINATED NO. 999999—
Sep 4, 2013OP.DOPPOSITION DISMISSED NO. 999999—
Mar 16, 2012OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 26, 2011ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 20, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 17, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 11, 2011AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Aug 10, 2011ALIEASSIGNED TO LIE—
Aug 10, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 10, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Aug 10, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 10, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 10, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 10, 2011IUAAUSE AMENDMENT ACCEPTED—
Aug 10, 2011DOCKASSIGNED TO EXAMINER—
Jul 12, 2011AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Jul 12, 2011IUAFUSE AMENDMENT FILED—
Jul 11, 2011EAAUTEAS AMENDMENT OF USE RECEIVED—
Jun 29, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 6, 2011MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
May 5, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 3, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance